BioSpace News Archive

Mainz Biomed N.V. announced a strategic partnership with TomaLab to launch the Company’s flagship product, ColoAlert® in Italy.

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference at the Boston Marriott Copley Place in Boston, Massachusetts, on March 4, 2024.

BioSyent Inc. is pleased to announce that it has been named to the 2024 TSX Venture 50 list as one of the top performers on the TSX Venture Exchange.

Madrigal Pharmaceuticals, Inc. today announced that the company granted equity awards to 46 new employees, in each case with a grant date of February 15, 2024, as equity inducement awards under the terms of the company’s 2023 Inducement Plan.

Vaccinex, Inc. (Nasdaq: VCNX) announces that it has entered into eight new antibody discovery agreements integrating use of its proprietary ActivMAb platform to select antibodies against difficult-to-drug transmembrane protein targets.

CervoMed Inc. today announced that Company’s Management will present at the BIO CEO and Investor Conference on February 26, 2024, being held in New York, NY and participate in one-on-one investor meetings.

aTyr Pharma, Inc. today announced plans to initiate an Individual Patient Expanded Access Program (EAP) for its lead therapeutic candidate, efzofitimod, for patients with pulmonary sarcoidosis.

Halia Therapeutics today announced that David J. Bearss , Ph.D., President and CEO of Halia Therapeutics, will present at the BIO CEO & Investor Conference on Tuesday, February 27.

Intensity Therapeutics, Inc. today announced that Lewis H. Bender, President and Chief Executive Officer, will present a company overview at the 2024 BIO CEO & Investor Conference on Monday, February 26, 2024, at the New York Marriott Marquis at 11:45am ET in the Uris Room.

ADARx Pharmaceuticals, Inc. today announced that Zhen Li, PhD, Co-Founder, President and CEO, will host one-on-one investor meetings at the 44th Annual Cowen Healthcare Conference on Monday, March 4, 2024 in Boston, Massachusetts.